NKGen Biotech, Inc.
NKGN
$0.1275
$0.00151.19%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 13.89% | -196.03% | -180.56% | -210.06% | -- |
| Total Depreciation and Amortization | 6.20% | 3.90% | 1.24% | -0.58% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -37.62% | 772.99% | 929.40% | 1,847.14% | -- |
| Change in Net Operating Assets | 369.24% | 1,215.07% | 754.44% | 7,320.00% | -- |
| Cash from Operations | -1.91% | -1.15% | 2.54% | 2.70% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.28% | 49.23% | 43.09% | 22.58% | -- |
| Cash from Investing | 57.14% | 102.86% | 100.00% | 70.55% | -- |
| Total Debt Issued | -60.66% | -6.38% | 0.13% | 15.24% | -- |
| Total Debt Repaid | -- | -- | 33.77% | 55.56% | -- |
| Issuance of Common Stock | -79.17% | 936.02% | 954.09% | 943.48% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 138.23% | -95.32% | -- | -- | -- |
| Cash from Financing | -58.98% | -9.28% | -6.88% | -1.47% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -198.32% | -202.51% | -217.77% | 167.95% | -- |